STAT3 inhibition combined with gemcitabine remodels the tumor stroma to enhance tumor drug delivery and improve survival in a genetic mouse model of pancreatic cancer.
STAT3 inhibition combined with gemcitabine remodels the tumor stroma to enhance tumor drug delivery and improve survival in a genetic mouse model of pancreatic cancer.